推荐产品
等级
certified reference material
质量水平
表单
liquid
特点
SNAP-N-SPIKE®. SNAP-N-SHOOT®
包装
ampule of 1 mL
制造商/商品名称
Cerilliant®
drug control
Narcotic Licence Schedule B (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal)
浓度
1.0 mg/mL in methanol
技术
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
应用
forensics and toxicology
包装形式
single component solution
储存温度
−20°C
SMILES字符串
O=C(NC(C1(CC)CCC(C)C)=O)NC1=O
InChI
1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)
InChI key
VIROVYVQCGLCII-UHFFFAOYSA-N
一般描述
经认证的加标溶液®，用于通过GC/MS或LC/MS进行的异戊巴比妥检测方法，用于临床毒理学、药物监测、法医分析、疼痛处方监测或尿液药物检测应用。异戊巴比妥是批准用于焦虑、失眠和癫痫治疗的巴比妥酸盐。
应用
- Barbiturate biochemical analysis: A study detailed a new approach for the analysis of barbiturates, including amobarbital, using ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS), highlighting advancements in detecting and quantifying these substances in forensic and toxicological contexts (Wachełko et al., 2023).
法律信息
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
相关产品
产品编号
说明
价格
警示用语：
Danger
危险分类
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
靶器官
Eyes,Central nervous system
储存分类代码
3 - Flammable liquids
WGK
WGK 2
闪点(°F)
49.5 °F - closed cup
闪点(°C)
9.7 °C - closed cup
法规信息
监管及禁止进口产品
Julián Carvajal-Castrillón et al.
Revista de neurologia, 55(9), 520-527 (2012-11-01)
An appropriate localization of ictal onset zone in refractory temporal lobe epilepsy favors an adequate outcome associated with surgical treatment. When video-electroencephalogram (video-EEG) and magnetic resonance imaging do not provide accurate data to locate ictal onset zone, the use of
Propofol, amobarbital… is it the substance that matters, or the question about the role of the Wada test in brain tumor patients?
Karl Schaller
World neurosurgery, 75(3-4), 428-430 (2011-05-24)
Daniel L Drane et al.
Epilepsia, 53(10), 1790-1798 (2012-07-12)
Exclusive right hemisphere language lateralization is rarely observed in the Wada angiography results of epilepsy surgery patients. Cortical stimulation mapping (CSM) is infrequently performed in such patients, as most undergo nondominant left hemisphere resections, which are presumed not to pose
Impact of pretreatment with amobarbital on electroconvulsive therapy outcomes.
Clint Ross et al.
The journal of ECT, 29(1), e10-e11 (2013-02-21)
Scott D Spritzer et al.
The neurologist, 18(5), 329-331 (2012-08-31)
Presurgical evaluation for refractory epilepsy typically includes assessment of cognitive and language functions. The reference standard for determination of hemispheric language dominance has been the intracarotid amobarbital test (IAT) but functional magnetic resonance imaging (fMRI) is increasingly used. To critically
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门